Robot-Based Gait Training for Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing if the CPWalker, a robotic device that supports and guides children with cerebral palsy, can help improve their walking ability. The goal is to see if these children can walk better after several training sessions. The CPWalker is a robotic device designed to support and guide children with cerebral palsy, and similar robotic systems have shown effectiveness in improving gait and quality of life in children with CP.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that ongoing botox injections are not allowed.
Is robot-based gait training safe for children with cerebral palsy?
Research shows that robot-based gait training, including the use of wearable exoskeletons, is generally safe and well-tolerated in children with cerebral palsy. Studies report that children were able to walk independently with the device, and it was safe even for those with severe motor impairments.12345
How is the CPWalker treatment different from other treatments for cerebral palsy?
The CPWalker treatment is unique because it uses an untethered exoskeletal robot to assist children with cerebral palsy in walking, providing a realistic walking experience by generating assistive torques during different phases of walking. This approach is different from traditional therapies as it allows for overground walking and adapts to the child's intended movements, potentially improving motor function, walking speed, and endurance.23567
What data supports the effectiveness of the treatment CPWalker for children with cerebral palsy?
Who Is on the Research Team?
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Are You a Good Fit for This Trial?
This trial is for children and young adults aged 11-21 with Cerebral Palsy, specifically spastic diplegia. They should weigh no more than 75kg, be between approximately 110cm to 170cm tall, and have a certain level of motor function (GMFCS score of 2-4). Participants must understand verbal instructions and fit the CPWalker's size requirements. Those with recent surgeries, ongoing botox treatments, severe deformities or cognitive impairments that prevent understanding exercises are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Baseline testing sessions to assess initial gait parameters and functional mobility
Treatment
Participants engage in an 8-week CPWalker training program with 16-24 sessions
Post-training Testing
Post-training testing sessions to evaluate changes in gait and functional mobility
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CPWalker
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor